Please login to the form below

Not currently logged in
Email:
Password:

Cardiovascular outcomes

This page shows the latest Cardiovascular outcomes news and features for those working in and with pharma, biotech and healthcare.

Roche partners with Alnylam on hypertension therapy in deal worth up to $2.8bn

Roche partners with Alnylam on hypertension therapy in deal worth up to $2.8bn

Hypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. ... cardiovascular outcomes data in hand at launch to ensure results relevant not only for health authorities but also for access and clinical

Latest news

More from news
Approximately 1 fully matching, plus 135 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Prof Sir Mike Richards joins Incisive Health as senior counsel Prof Sir Mike Richards joins Incisive Health as senior counsel

    In July 2012 he was appointed as Director for Reducing Premature Mortality on the NHS Commissioning Board (now NHS England), where he led the development of a cardiovascular outcomes strategy. ... These are vital attributes if the NHS is to navigate the

  • Teva's Mark Salyer joins Amarin Teva's Mark Salyer joins Amarin

    Salyer’s appointment comes at a key juncture for Amarin as it awaits next year’s publication of results from the REDUCE-IT cardiovascular outcomes trial.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • World Heart Day 2020: It's time to make our clinical trials more inclusive World Heart Day 2020: It's time to make our clinical trials more inclusive

    Disparities in cardiovascular health outcomes between different ethnic groups. Despite the progress that’s been made in treating heart disease, there is still a huge difference in mortality between white people ... Health outcomes are also related to

  • A new vision for tackling key illnesses

    It also looks at other areas, such as cardiovascular and respiratory conditions, and explains how the NHS plans to change its approach in order to drive improvements in patient care and ... outcomes. Cardiovascular disease (CVD). Cardiovascular disease

  • Conference research case study

    Our client had recently conducted a series of clinical trials with its breakthrough cardiovascular product, resulting in outcomes data which had the potential to give it a more competitive edge and ... Communication strategies and marketing messages were

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....